Treace Medical Concepts, Inc. has successfully completed the first cases using IntelliGuide™ PSI technology with the Adductoplasty® System, enabling personalized surgical corrections for midfoot deformities. The company plans to gradually expand access to this innovative AI-enabled solution, with a full market release expected in the first half of 2025.
Company Information
Company
Treace
Location
Ponte Vedra, Florida, United States
About
Treace Medical Concepts, Inc. is a medical technology company with the goal of advancing the standard of care for the surgical management of bunion deformities and related midfoot correction. Bunions are complex 3-dimensional deformities that originate from an unstable joint in the middle of the foot and affect approximately 65 million Americans1, of which Treace estimates 1.1 million are annual surgical candidates. Treace Medical has pioneered and patented the Lapiplasty® 3D Bunion Correction™ system – a combination of instruments, implants, and surgical methods designed to surgically correct all 3 planes of the bunion deformity and secure the unstable joint, addressing the root cause2,3 of the bunion and helping patients get back to their active lifestyles. Treace Medical has expanded its offering with the Adductoplasty™ Midfoot Correction System, designed for reproducible surgical correction of the midfoot to provide further support to hallux valgus patients.
Fundz sees it the moment Treace ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Ponte VedraManufacturingBiotechnologyHealthcareHealth CareMedicalMedical Device